Casi Pharmaceuticals Stock Price Prediction
| CASI Stock | USD 2.44 0.07 2.79% |
Oversold Vs Overbought
26
Oversold | Overbought |
CASI Pharmaceuticals stock price prediction is an act of determining the future value of CASI Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of CASI Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of CASI Pharmaceuticals and does not consider all of the tangible or intangible factors available from CASI Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with CASI Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of CASI Pharmaceuticals based on different types of headlines from major news networks to social media. The CASI stock price prediction module provides an analysis of price elasticity to changes in media outlook on CASI Pharmaceuticals over a specific investment horizon. Using CASI Pharmaceuticals hype-based prediction, you can estimate the value of CASI Pharmaceuticals from the perspective of CASI Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in CASI Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in CASI Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying CASI because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
CASI Pharmaceuticals after-hype prediction price | USD 3.25 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
CASI |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of CASI Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
CASI Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of CASI Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in CASI Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of CASI Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
CASI Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting CASI Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on CASI Pharmaceuticals' historical news coverage. CASI Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.16 and 8.39, respectively. We have considered CASI Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
CASI Pharmaceuticals is unstable at this time. Analysis and calculation of next after-hype price of CASI Pharmaceuticals is based on 3 months time horizon.
CASI Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as CASI Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading CASI Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with CASI Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.53 | 5.11 | 0.00 | 4.01 | 0 Events / Month | 2 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.44 | 3.25 | 33.20 |
|
CASI Pharmaceuticals Hype Timeline
CASI Pharmaceuticals is currently traded for 2.44. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 4.01. CASI is projected to increase in value after the next headline, with the price projected to jump to 3.25 or above. The average volatility of media hype impact on the company the price is insignificant. The price growth on the next news is projected to be 33.2%, whereas the daily expected return is currently at -1.53%. The volatility of related hype on CASI Pharmaceuticals is about 195.04%, with the expected price after the next announcement by competition of 6.45. The company currently holds 21.24 M in liabilities with Debt to Equity (D/E) ratio of 0.03, which may suggest the company is not taking enough advantage from borrowing. CASI Pharmaceuticals has a current ratio of 3.15, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist CASI Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, CASI Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CASI Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CASI to invest in growth at high rates of return. When we think about CASI Pharmaceuticals' use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next projected press release will be in 5 to 10 days. Check out CASI Pharmaceuticals Basic Forecasting Models to cross-verify your projections.CASI Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to CASI Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict CASI Pharmaceuticals' future price movements. Getting to know how CASI Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how CASI Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| VBLT | Vascular Biogenics | 0.02 | 3 per month | 0.00 | (0.12) | 9.09 | (7.69) | 43.92 | |
| CBIO | Catalyst Biosciences | 0.04 | 7 per month | 5.45 | 0.13 | 23.26 | (10.91) | 39.30 | |
| CLRB | Cellectar Biosciences | 0.00 | 0 per month | 0.00 | (0.07) | 9.34 | (5.75) | 21.31 | |
| CDTX | Cidara Therapeutics | 13.04 | 8 per month | 0.00 | (0.02) | 9.26 | (7.76) | 38.31 | |
| CFRX | ContraFect Corp | 0.00 | 0 per month | 0.00 | (0.13) | 10.33 | (18.38) | 26.95 |
CASI Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine CASI price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for CASI using various technical indicators. When you analyze CASI charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About CASI Pharmaceuticals Predictive Indicators
The successful prediction of CASI Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as CASI Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of CASI Pharmaceuticals based on analysis of CASI Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to CASI Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to CASI Pharmaceuticals's related companies. Story Coverage note for CASI Pharmaceuticals
The number of cover stories for CASI Pharmaceuticals depends on current market conditions and CASI Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that CASI Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about CASI Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
CASI Pharmaceuticals Short Properties
CASI Pharmaceuticals' future price predictability will typically decrease when CASI Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of CASI Pharmaceuticals often depends not only on the future outlook of the potential CASI Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. CASI Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 13.4 M | |
| Cash And Short Term Investments | 30.8 M |
Check out CASI Pharmaceuticals Basic Forecasting Models to cross-verify your projections. For more detail on how to invest in CASI Stock please use our How to Invest in CASI Pharmaceuticals guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for CASI Stock analysis
When running CASI Pharmaceuticals' price analysis, check to measure CASI Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CASI Pharmaceuticals is operating at the current time. Most of CASI Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of CASI Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CASI Pharmaceuticals' price. Additionally, you may evaluate how the addition of CASI Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |
Is CASI Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CASI Pharmaceuticals. If investors know CASI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CASI Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of CASI Pharmaceuticals is measured differently than its book value, which is the value of CASI that is recorded on the company's balance sheet. Investors also form their own opinion of CASI Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is CASI Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CASI Pharmaceuticals' market value can be influenced by many factors that don't directly affect CASI Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CASI Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if CASI Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CASI Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.